SEC 13F Intelligence

Neuberger Berman Group LLC / BSX

Neuberger Berman Group LLC’s Boston Scientific Corp Position

Does Neuberger Berman Group LLC own Boston Scientific Corp (BSX)? Yes — 7.07M shares worth $444M (+0.34% of its 13F portfolio) as of Q1 2026, up from 4.01M shares the prior filed quarter.

Position Value
$444M
Q1 2026
Shares
7.07M
% of Portfolio
+0.34%
Quarters Held
30
currently held

Position History BSX

Reported value by quarter
Q4 ’18: $210MQ4 ’18Q1 ’19: $209MQ2 ’19: $250MQ3 ’19: $234MQ4 ’19: $257MQ4 ’19Q1 ’20: $111MQ2 ’20: $118MQ3 ’20: $117MQ4 ’20: $141MQ4 ’20Q1 ’21: $243MQ2 ’21: $263MQ3 ’21: $190MQ4 ’21: $176MQ4 ’21Q1 ’22: $231MQ2 ’22: $214MQ3 ’22: $146MQ4 ’22: $196MQ4 ’22Q1 ’23: $465MQ2 ’23: $534MQ3 ’23: $354MQ4 ’23: $238MQ4 ’23Q1 ’24: $269MQ2 ’24: $311MQ3 ’24: $336MQ4 ’24: $359MQ4 ’24Q1 ’25: $395MQ2 ’25: $425MQ3 ’25: $389MQ4 ’25: $382MQ4 ’25Q1 ’26: $444Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.07M$444M+0.34%
Q4 20254.01M$382M+0.28%
Q3 20253.99M$389M+0.28%
Q2 20253.96M$425M+0.33%
Q1 20253.92M$395M+0.33%
Q4 20244.02M$359M+0.29%
Q3 20244.01M$336M+0.26%
Q2 20244.03M$311M+0.25%
Q1 20243.92M$269M+0.22%
Q4 20234.11M$238M+0.21%
Q3 20236.71M$354M+0.32%
Q2 20239.89M$534M+0.48%
Q1 20239.30M$465M+0.43%
Q4 20224.24M$196M+0.19%
Q3 20223.77M$146M+0.15%
Q2 20225.75M$214M+0.22%
Q1 20225.23M$231M+0.20%
Q4 20214.15M$176M+0.14%
Q3 20214.39M$190M+0.17%
Q2 20216.15M$263M+0.23%
Q1 20216.30M$243M+0.23%
Q4 20203.92M$141M+0.15%
Q3 20203.08M$117M+0.14%
Q2 20203.36M$118M+0.15%
Q1 20203.39M$111M+0.17%
Q4 20195.68M$257M+0.30%
Q3 20195.76M$234M+0.29%
Q2 20195.81M$250M+0.30%
Q1 20195.44M$209M+0.26%
Q4 20185.94M$210M+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neuberger Berman Group LLC’s full portfolio or all institutional holders of BSX.